Network origin in Alain Fischer first degree
Entity | Entity type | Industry | |
---|---|---|---|
Fondation Bettencourt Schueller
12
| Foundation/Endowment | Investment Trusts/Mutual Funds | 12 |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Alain Fischer via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
IsoTis, Inc.
IsoTis, Inc. Medical SpecialtiesHealth Technology IsoTis, Inc. designs, manufactures and sells bone graft substitutes and other devices. The company was founded on November 15, 2006 and is headquartered in Plainsboro, NJ. | Medical Specialties | Corporate Officer/Principal | |
POXEL | Pharmaceuticals: Major | Director/Board Member | |
Arthur D. Little, Inc.
Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
HSBC Continental Europe
HSBC Continental Europe Regional BanksFinance HSBC Continental Europe provides banking and asset management services. The firm offers corporate finance, treasury, capital markets, new issues and origination, and security services. The company was founded in 1894 and is headquartered in Paris, France. | Regional Banks | Chairman | |
L'ORÉAL | Household/Personal Care | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Beerse Betonhandel
Beerse Betonhandel Regional BanksFinance Part of Douterloigne Betonwerken, Beerse Betonhandel is a Belgian company that has a description related to depository banking functions not classified elsewhere. Beerse Betonhandel was acquired by Douterloigne Betonwerken on February 01, 1999. | Regional Banks | Corporate Officer/Principal | |
Tethys SCA | Chairman Chief Executive Officer | ||
Organon International, Inc.
Organon International, Inc. Pharmaceuticals: MajorHealth Technology Organon International, Inc. manufactures and markets pharmaceutical products. It develops therapeutics in the fields such as gynecology, fertility, osteoporosis, and anesthesia. The company was founded in 1923 and is located in Roseland, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
L'Oréal USA, Inc.
L'Oréal USA, Inc. Medical DistributorsDistribution Services L'Oréal USA, Inc. manufactures and distributes cosmetics, concentrating on hair color, skin care, sun protection, make-up, perfumes, and hair care. The company was founded in 1953 and is headquartered in New York, NY. | Medical Distributors | Director/Board Member Director/Board Member Chairman | |
ADEMTECH SA
ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member | |
The University of Nottingham | College/University | Corporate Officer/Principal | |
Glaxo Group Ltd.
Glaxo Group Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1935, Glaxo Group Ltd. is a subsidiary of GSK Plc. The company is based in Middlesex, UK. At GSK, we unite science, technology and talent to get ahead of disease together. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Utrecht | College/University | Graduate Degree | |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Chief Executive Officer | |
École Centrale Paris | College/University | Undergraduate Degree | |
L'Oréal (UK) Ltd.
L'Oréal (UK) Ltd. Wholesale DistributorsDistribution Services L'Oréal (UK) Ltd. produces cosmetics and perfumes. It has various brands in professional products, consumer products, luxury products, active cosmetics and the body shop. The company was founded in 1907 by Eugne Schueller and is located in London, UK. | Wholesale Distributors | Director/Board Member Director/Board Member | |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Analyst | |
The National Institute For Medical Research | College/University | Doctorate Degree | |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
TXCELL | Miscellaneous Commercial Services | Director/Board Member | |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Manchester Business School | College/University | Masters Business Admin | |
Clymene SAS | Chairman Chief Executive Officer | ||
SENSORION | Pharmaceuticals: Major | Director/Board Member | |
BIOM'UP | Medical Specialties | Director/Board Member | |
ADVICENNE | Pharmaceuticals: Generic | Director/Board Member | |
Sygnature Discovery Ltd.
Sygnature Discovery Ltd. Pharmaceuticals: MajorHealth Technology Sygnature Discovery Ltd. engages in drug discovery activities. It specializes in target validation, hit identification, hit to lead, lead optimization, integrated drug discovery, and fragment based drug discovery. The company was founded by Simon Christopher Hirst in 2004 and is headquartered in Nottingham, United Kingdom. | Pharmaceuticals: Major | Founder Director/Board Member | |
HeatMatrix Group BV
HeatMatrix Group BV Building ProductsProducer Manufacturing HeatMatrix Group BV develops and manufactures plastic heat exchangers for waste heat recovery from industrial corrosive flue gas. The firm’s heat exchangers can be used in the petrochemicals and chemicals, bio-energy, food, agricultural, and paper industries. Its products include air pre-heater, hybrid exchanger, gas to liquid, and in situ cleaning system. The company was founded by Erik van den Berg in 2008 and is headquartered in Geldermalsen, the Netherlands. | Building Products | Founder | |
Tethys SAS
Tethys SAS Aerospace & DefenseElectronic Technology Tethys SAS is a French company that specializes in designing, developing, and manufacturing equipment and systems using pyrotechnics, micromechanics, and precision electronics technologies. The company is based in Signes, France, and has subsidiaries in France. Tethys was founded by Patricia Bourbonne, and the CEO is Marc Schwindenhammer. | Aerospace & Defense | Chairman Director/Board Member | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
GamaMabs Pharma SA
GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member | |
CorWave SA
CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Memo Therapeutics AG
Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Biotechnology | Chief Executive Officer | |
GENEURO SA | Biotechnology | Director/Board Member | |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Director/Board Member | |
Téthys Invest SASU
Téthys Invest SASU Investment ManagersFinance Téthys Invest SASU is a Private Equity firm, a subsidiary of Tethys SAS (Île-de-France) founded in 2015. Téthys Invest SASU is headquartered in Neuilly-sur-Seine. | Investment Managers | Chairman Chairman | |
Agir Pour Laudition
Agir Pour Laudition Miscellaneous Commercial ServicesCommercial Services Agir Pour L'Audition is a non-profit company based in Paris, France that provides hearing health care services. | Miscellaneous Commercial Services | Director/Board Member President | |
LimFlow SA
LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
BioAscent Discovery Ltd.
BioAscent Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services BioAscent Discovery Ltd. provides integrated drug discovery services. The firm offers compound management and compound reformatting services. Its products include readymade screening libraries, custom screening libraries and follow-up samples. The company was founded by Sylviane Boucharens in 2013 and is headquartered in Motherwell, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
LAVA THERAPEUTICS N.V. | Biotechnology | Founder | |
NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member | |
Fondation Pour L'Audition
Fondation Pour L'Audition Medical DistributorsDistribution Services Fondation Pour L'Audition is a French public-interest organization that aims to promote hearing health and improve the lives of people with hearing loss. The private company is based in Paris, France. The foundation collaborates with various actors, both French and foreign, in its research missions. Its goal is to unite talents to advance the cause of hearing health and help the deaf, hard of hearing, and their loved ones live better lives. | Medical Distributors | Chairman Chairman | |
Tridek-One Therapeutics SAS
Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Miscellaneous Commercial Services | Director/Board Member | |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | Medical Specialties | Director/Board Member | |
Lead Pharma Holding BV
Lead Pharma Holding BV Pharmaceuticals: MajorHealth Technology Lead Pharma Holding BV develops small-molecule drugs for the treatment of autoimmune diseases and cancer. It specializes in medicinal, computational, and protein chemistry, x-ray crystallography, cell biology, and integration x-omics. The company was founded by Ad van Gorp, Leon de Windt, and Pieter Doevendans in 2007 and is headquartered in Oss , the Netherlands. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
France | 27 |
United Kingdom | 9 |
Netherlands | 7 |
United States | 5 |
Belgium | 3 |
Sectoral
Health Technology | 25 |
Commercial Services | 7 |
Consumer Services | 7 |
Finance | 6 |
Distribution Services | 4 |
Operational
Director/Board Member | 110 |
Chairman | 31 |
Corporate Officer/Principal | 29 |
Chief Executive Officer | 19 |
Independent Dir/Board Member | 14 |
Most connected contacts
- Stock Market
- Insiders
- Alain Fischer
- Company connections